Pharma giant funds technology to help detect heart condition in Devon   

Pharmaceutical company Bayer PLC has awarded the South West Academic Health Science Network over £5,000 to help detect irregular heart rhythms among people living in Devon.
The funding, nearly £5,500 in total, will be used by the podiatry team at Torbay and South Devon NHS Foundation Trust to purchase tablets to help detect atrial fibrillation (AF) – the most common form of cardiac arrhythmia.
The new tablets will enable use of pulse check apps including KardiaMobile, an app which uses a patient’s fingers to detect common heart arrhythmias, and AliveCor – a small handheld device which can be pressed against a patient’s skin to record their heart rhythm. Podiatrists can detect atrial fibrillation in patients by checking the pulse in their feet.
According to Public Health England (2017), people with AF have a five-times higher risk of stroke. Up to 66% of AF-related strokes, the most devastating form of stroke, could be averted with treatment.
The South West Academic Health Science Network, alongside the 14 other Academic Health Science Networks (AHSNs) in England are working together to support improvements in AF detection and practice.
For more information about our work on atrial fibrillation, please visit our page.

You may also be Interested in

AHSN Network supported companies generate £455 million of UK investment  

AHSN Network supported companies generate £455 million of UK investment  

Read more
New funding & vacancy to grow South West mental health equity research

New funding & vacancy to grow South West mental health equity research

Read more
BLOG: Spreading innovation in health & care – why context matters

BLOG: Spreading innovation in health & care – why context matters

Read more
Newsletter

Stay up to date

Sign up to our newsletter for all the latest news and events